Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
about
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinomaSquamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationEvidence-based review of treatment options for patients with glottic cancer.Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. ESignificant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.Palliative treatment of patients with inoperable locally advanced, recurrent or metastatic head and neck squamous cell cancer, using a low-dose and personalized chemotherapeutic regimen.Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer.Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy.Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer[Multimodal laryngeal preservation: current data-based opinion].Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer.Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis.Transoral microsurgery for treatment of laryngeal and pharyngeal cancers.Is open surgery for head and neck cancers truly declining?Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancerInduction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancerInduction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 studyInduction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer.Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.Analysis and results of Ku and XRCC4 expression in hypopharyngeal cancer tissues treated with chemoradiotherapy.Induction Chemotherapy with Cisplatin and 5-Fluorouracil in Advanced Head and Neck Cancers: A Short Term Response EvaluationLaryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891Systemic therapy strategies for head-neck carcinomas: Current statusPrognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies.Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.A genetic view of laryngeal cancer heterogeneityTen years of progress in head and neck cancers.Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan.Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients.MicroRNA-17-5p regulated apoptosis-related protein expression and radiosensitivity in oral squamous cell carcinoma caused by betel nut chewing.Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes.Chemotherapy regimens and treatment protocols for laryngeal cancer.Radiotherapy for laryngeal squamous cell carcinoma: current standards.Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer.Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis.
P2860
Q24200903-38624DD9-DF47-425D-85A7-E6E30894643EQ26765060-EA869101-4CBA-4FCB-B20B-8C60095F8F26Q31032091-E6E588D1-80AD-4548-818A-4673696AA0BCQ33393655-F03F5CAC-1FB1-4BA2-840A-6688CC1F080FQ33433507-97F2DCC0-A3F7-4D42-832E-59A798565CA4Q33442582-A4EDDED4-67C7-4003-B480-DE5E8102DDDAQ33590769-3D43B34D-5199-48F1-A047-7EB373DA9858Q33750798-748413F8-AF5D-473E-A9AC-0682BE724483Q33837008-71DF9BB5-A43E-4B86-BA98-32BB35706CC1Q33870104-FF96F5A2-B6F7-470E-BAA1-0A9C327DA2D6Q33990915-78CE5BF6-ADA4-4B97-BC8C-FCFC758E2946Q34142639-847AF8C7-27CD-4C28-BE28-E8471B9010F5Q34477841-2853D5B0-6971-45CD-A19B-E35A714AC1ABQ34511068-80DD60FB-A9EE-42E1-8055-EF4A65FB1857Q34527550-ECA073DE-CB16-4039-B9C2-8779FE94428FQ34530861-DC237744-B388-4026-952B-2018058FAF9DQ34691622-459466B2-048C-4A34-A8FD-FCA64D8D240AQ35169306-7E18CE43-37FE-4F8C-87DC-78EE92641AB9Q35206363-D8FB1B33-1324-401F-9F6A-8B03A1125473Q35602143-EFE6E82E-C319-4759-BC81-53042B23B85FQ35652246-47C59B85-0827-4586-AC04-5E854576FCD2Q35828640-76A87E7A-EA43-4448-B245-60FD4E6AA15BQ36049570-BFE2F6F0-AE91-4211-86EA-79B5FF8BBB9AQ36099339-15500792-3A19-4554-9C9F-6E8929636BADQ36222274-B673C754-D738-400B-A148-12DAA404BB6CQ36278108-32F529E3-2D7B-444E-B34A-275E48067BD5Q36529843-1D9B4923-3FD4-49C1-9D7C-2B759696D76BQ36552692-3301134A-B161-4F5B-A997-A3B5A17A3B97Q36625201-526933ED-E8A8-4CEB-9D78-31B7F59B8DF6Q36838932-93B5960F-2BF5-4F4C-A414-8F6F594AB0FEQ36972817-99AF1F66-BF1F-45B2-B43F-7B7FFF4AD601Q37002445-7AB309DF-B188-4066-91D7-13A3DDA1F4EAQ37206229-EFDAB055-4786-431E-8E9C-54360F3293FEQ37392967-C6E5BD7E-88C6-4E84-8458-81CBD1570929Q37588307-22A9F0CD-B176-4EB7-9470-D8B6A1A9220DQ37658806-60FF01C8-7FBC-4064-95A8-98DF6F5E68FFQ37739426-FEDB1208-5A26-400B-B6DF-7B6136CD77C9Q37788244-53E6E95C-ED17-46EE-A12E-C87EB47E2131Q37799933-062542A2-7C73-4946-A0B2-5118FF56111BQ37801330-4BF0D591-052E-443D-A580-D7547A2AE649
P2860
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Randomized trial of induction ...... taxel for larynx preservation.
@ast
Randomized trial of induction ...... taxel for larynx preservation.
@en
type
label
Randomized trial of induction ...... taxel for larynx preservation.
@ast
Randomized trial of induction ...... taxel for larynx preservation.
@en
prefLabel
Randomized trial of induction ...... taxel for larynx preservation.
@ast
Randomized trial of induction ...... taxel for larynx preservation.
@en
P2093
P2860
P356
P1476
Randomized trial of induction ...... taxel for larynx preservation.
@en
P2093
Christian Sire
Claude Tuchais
Gilles Calais
Jacques Tortochaux
Marc Alfonsi
Pascal Garaud
Sophie Chapet
Stephane Guerrif
Yoann Pointreau
P2860
P304
P356
10.1093/JNCI/DJP007
P407
P577
2009-03-24T00:00:00Z